Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Specific Biomarkers for Anaplastic Thyroid Carcinoma Through Spatial Transcriptomic and Immunohistochemical Profiling. | Endocr Pathol | 2025 | 40244468 | PubTator, text mining | PubMed |
| A model of basement membrane-related regulators for prediction of prognoses in esophageal cancer and verification in vitro. | BMC Cancer | 2025 | 40234833 | PubTator, text mining | PubMed |
| EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer. | Mol Cancer | 2025 | 40121428 | PubTator, text mining | PubMed |
| MuCST: restoring and integrating heterogeneous morphology images and spatial transcriptomics data with contrastive learning. | Genome Med | 2025 | 40082941 | PubTator, text mining | PubMed |
| A single-cell map of patients with non-small cell lung cancer harboring rare-driver mutations after anti-PD-1 treatment. | Cancer Lett | 2025 | 40021042 | PubTator, text mining | PubMed |
| miR-212-5p Regulates PM2.5-Induced Apoptosis by Targeting LAMC2 and LAMA3. | Int J Mol Sci | 2025 | 40004224 | PubTator, text mining | PubMed |
| Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma. | BJC Rep | 2025 | 39809945 | PubTator, text mining | PubMed |
| Knockdown of LAMA3 enhances the sensitivity of colon cancer to oxaliplatin by regulating the Hippo-YAP pathway. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39798821 | PubTator, text mining | PubMed |
| Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT signaling cascade. | Life Sci | 2025 | 39778762 | PubTator, text mining | PubMed |
| Gingival keratinocyte adhesion on atomic layer-deposited hydroxyapatite coated titanium. | J Biomater Appl | 2025 | 39773092 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis identifies subclusters and signature with N-glycosylation in endometrial cancer. | Clin Transl Oncol | 2025 | 39589706 | PubTator, text mining | PubMed |
| 20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters. | J Adv Res | 2025 | 39270979 | PubTator, text mining | PubMed |
| Tibial cortex transverse transport surgery improves wound healing in patients with severe type 2 DFUs by activating a systemic immune response: a cross-sectional study. | Int J Surg | 2025 | 38954658 | PubTator, text mining | PubMed |
| Integrating traditional machine learning with qPCR validation to identify solid drug targets in pancreatic cancer: a 5-gene signature study. | Front Pharmacol | 2024 | 39850570 | PubTator, text mining | PubMed |
| Fructo-Oligosaccharides Enhance the Expression of Genes Related to Focal Adhesion- and Inflammation-Pathways in Small Intestinal Absorptive Caco-2 Cells. | J Nutr Sci Vitaminol (Tokyo) | 2024 | 39756968 | PubTator, text mining | PubMed |
| Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes. | Nat Commun | 2024 | 39738080 | PubTator, text mining | PubMed |
| Vascular Basement Membrane Fragmentation in Keloids and the Expression of Key Basement Membrane Component Genes. | Plast Reconstr Surg Glob Open | 2024 | 39717721 | PubTator, text mining | PubMed |
| Physical activity promotes the development of cognitive ability in adolescents: the chain mediating role based on self-education expectations and learning behaviors. | Front Psychol | 2024 | 39649782 | PubTator, text mining | PubMed |
| NSUN2 Promotes Head and Neck Squamous Cell Carcinoma Progression by Targeting EMT-Related Gene LAMC2 in an m5C-YBX1-Dependent Manner. | Biomedicines | 2024 | 39595099 | PubTator, text mining | PubMed |
| ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer. | NPJ Precis Oncol | 2024 | 39496753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=5